Navigation Links
Afraxis Appoints Carmine Stengone President and Chief Executive Officer, and Christopher Rex, Ph.D., Chief Scientific Officer
Date:4/29/2013

SAN DIEGO, April 29, 2013 /PRNewswire/ -- Afraxis, Inc. today announced that it has appointed Carmine Stengone as the company's president and chief executive officer. The company has also appointed Christopher Rex , Ph.D. as chief scientific officer.

In his previous role as vice president of corporate development for Afraxis Holdings, Mr. Stengone led and executed a $187.5 million license agreement with Roche's subsidiary, Genentech.  After the transaction, Mr. Stengone helped establish Afraxis, Inc. as a spin-out from Afraxis Holdings.  Afraxis, Inc. is a start-up company focusing on its novel Enhanced Spine Platform (ESP) Technology which assesses complex neural networks to evaluate preclinical efficacy and safety of drug candidates in central nervous system (CNS) disorders. 

"Carmine is a rising young star in the life science industry with an impressive track record in negotiating and executing on licensing deals and alliances with major pharma partners, and using his experience, he will generate a pipeline of lucrative collaborations with companies that want to capitalize on Afraxis' ESP technology platform for their own drug discovery efforts." said Jay Lichter , Ph.D., chairman of Afraxis, and managing partner of Avalon Ventures. "Chris led the development of the ESP technology, and his expertise in central nervous system biology will be integral to further expanding the platform as a premiere preclinical drug discovery tool for companies interested in developing treatments for CNS disorders."

Mr. Stengone, 37, has more than 14 years of experience in the pharmaceutical and biotechnology industries, including positions in finance, strategic planning, corporate development, licensing, alliance management and venture funding. In addition to his role as CEO of Afraxis, Inc., Mr. Stengone also se
'/>"/>

SOURCE Afraxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Afraxis Grants Exclusive Global License to Genentech
2. BioDelivery Sciences Appoints Thomas W. DAlonzo to Board of Directors
3. National Association of Specialty Pharmacy (NASP) Appoints Thomas Blissenbach, RPh, MS as a Member of The Board of Directors
4. Pro-Dex, Inc. Appoints Richard Van Kirk Chief Operating Officer
5. Vapotherm Closes Financing Round, Appoints James Liken as Chairman of the Board and Opens New Corporate Headquarters
6. PTC Therapeutics Appoints Mark Rothera As Chief Commercial Officer
7. BioRestorative Therapies Appoints ProActive Capital Group as Capital Markets & Digital Media Advisor
8. Venaxis Appoints SomaLogic CMO and former Pfizer Executive Stephen A. Williams, M.D., Ph.D., to Board of Directors
9. Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development
10. MetaStat Appoints David Epstein, Ph.D. as Advisor to Lead Drug Discovery
11. Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... -- ResMed Inc. (NYSE: RMD ) today announced results ... the quarter was $453.1 million, a 9 percent increase ... 17 percent increase on a constant currency basis).  Net ... June 30, 2014.  Diluted earnings per share for the ... 30, 2014.  The results for the ...
(Date:7/30/2015)... and VANCOUVER , July ... ) announced today that it will report its second ... Company management will host a conference call and live ... overview of financial results, clinical development programs and a ... webcast, log on to the Investor Relations page of ...
(Date:7/30/2015)... , July 30, 2015  Cleveland Clinic President ... 2015 keynote address last month that industry is compelled ... order to gain the efficiencies—and develop the transformational innovations ... Dr. Barsoum,s comments were preceded by Doug Kohrs ... and OMTEC moderator, who stressed that industry must add ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... Inc. (Nasdaq: SLTM ), a global leader in ... 69, Chief Technology Officer and a member of the company,s ... 1, 2010. Mr. DeBenedictis will be available to advise the ... to remain active in the development of other emerging medical ...
... Md., Sept. 15 The U.S. Food and Drug ... Department of Justice (USDOJ), today announced that Forest Pharmaceuticals, ... company accepted responsibility for criminal actions including distribution of ... and obstruction of an FDA inspection. ...
Cached Medicine Technology:Len DeBenedictis Retires as Chief Technology Officer of Solta Medical, Inc. 2Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws 2Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws 3
(Date:8/2/2015)... (PRWEB) , ... August 03, 2015 , ... For many “would be” entrepreneurs, starting ... get help” or “I can’t afford to start a business.” Neither needs be a major ... right and theoretical opportunity to start a business and be successful. The risks of starting ...
(Date:8/2/2015)... ... ... Molecular biologists in New South Wales say a protein linked to cell proliferation ... article on the new research. Click here to read it now. , ... samples from 42 patients with peritoneal mesothelioma and found a direct correlation with outcomes. ...
(Date:8/1/2015)... ... August 02, 2015 , ... Back packs can be ... school, however, back packs can wreck havoc on a kid's spine. With school starting ... to and from school. Make sure you are aware of how to help them ...
(Date:8/1/2015)... ... , ... Have you ever wondered what “Karma” really means? Does it even exist? Can I ... Vedic tradition, which gave birth to Hinduism, is one of the most ancient spiritual and ... tradition. According to the wisdom of this heritage, Karma is a very real and powerful ...
(Date:8/1/2015)... ... August 01, 2015 , ... Calvary Hospital today announced ... at their Bronx campus. The goal is to bring this Torah – dating from ... in Jewish rituals and religious services. , Scroll No. 515, from the town ...
Breaking Medicine News(10 mins):Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 3Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 4Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 5Health News:Scientists Link Protein Marker with Mesothelioma Prognosis in New Study, According to Surviving Mesothelioma 2Health News:Local AlignLife Doctor Donates Time to Check Back Packs 2Health News:Nithyananda Yoga Foundation to Conduct Global Webinar on Karma at No Charge on August 1st 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3
... children could lead to confusion and a cut in the ... researchers in this week’s BMJ. ,According to the ... risen over the last twenty years, from an average of ... per year since 2000. In 2005, around 73 million people ...
... risk by blocking the lifesaving effects of aspirin//, a new ... is monstrous," Michael Farkouh, director of clinical trials at Mount ... ,“Ibuprofen is relatively safe except when we give ... attack," Farkouh says. "But when given with aspirin, we do ...
... sentenced a thirty-eight-year-old Italian chef, Mola, for deliberately infecting his ex-girlfriend, ... was proud of his escapades- 200 of them and never thought ... lady in question, Miss X after he was diagnosed HIV positive. ... honest with his partner and purposefully exposed her to the grave ...
... Scientists at the University of Pittsburgh School of ... treatments for prostate cancer are much more likely ... not receive hormone treatments for prostate cancer. ... a dizzying array of treatment options: radiation, seed ...
... may lower the risk of lung cancer among people ... ,Actually the inhaled corticosteroids are medications that are ... asthma symptoms. ,How inhaled corticosteroids work ... have been shown to reduce inflammation in the airways ...
... a small East African nation and very poor, has banned ... has said//. ,Anybody involved in female genital ... it said. ,The move follows a campaign ... which says more than 90% of Eritrean women are circumcised. ...
Cached Medicine News:Health News:New Standards Could Cut Number of Malnourished Children on Feeding Programs 2Health News:Ibuprofen Risky for Heart Patients? 2Health News:Links Between Prostate Cancer Treatment, Periodontal Disease 2Health News:Inhaled Corticosteroids may Reduce Lung Cancer Risk 2Health News:Eritrea Bans Female Circumcision 2
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: